Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:27PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 74.26B |
| Enterprise value | 65.85B |
| Trailing P/E | 23.44 |
| Forward P/E | 18.69 |
| PEG ratio (5-yr expected) | 0.39 |
| Price/sales (ttm) | 8.96 |
| Price/book (mrq) | 6.22 |
| Enterprise value/revenue | 7.89 |
| Enterprise value/EBITDA | 15.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.45 |
| 52-week change 3 | 66.18% |
| S&P500 52-week change 3 | -13.12% |
| 52-week high 3 | 305.95 |
| 52-week low 3 | 176.36 |
| 50-day moving average 3 | 287.92 |
| 200-day moving average 3 | 262.63 |
Share statistics
| Avg vol (3-month) 3 | 1.38M |
| Avg vol (10-day) 3 | 1.52M |
| Shares outstanding 5 | 256.46M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 255.86M |
| % held by insiders 1 | 0.23% |
| % held by institutions 1 | 94.36% |
| Shares short (14 Sept 2022) 4 | 2.89M |
| Short ratio (14 Sept 2022) 4 | 2.44 |
| Short % of float (14 Sept 2022) 4 | 1.13% |
| Short % of shares outstanding (14 Sept 2022) 4 | 1.13% |
| Shares short (prior month 14 Aug 2022) 4 | 2.57M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 23 Aug 2000 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | 38.26% |
| Operating margin (ttm) | 37.59% |
Management effectiveness
| Return on assets (ttm) | 14.11% |
| Return on equity (ttm) | 30.24% |
Income statement
| Revenue (ttm) | 8.35B |
| Revenue per share (ttm) | 32.64 |
| Quarterly revenue growth (yoy) | 22.50% |
| Gross profit (ttm) | 3.62B |
| EBITDA | 3.28B |
| Net income avi to common (ttm) | 3.19B |
| Diluted EPS (ttm) | 12.69 |
| Quarterly earnings growth (yoy) | 1,109.70% |
Balance sheet
| Total cash (mrq) | 9.25B |
| Total cash per share (mrq) | 36.08 |
| Total debt (mrq) | 847.3M |
| Total debt/equity (mrq) | 7.10 |
| Current ratio (mrq) | 4.50 |
| Book value per share (mrq) | 46.61 |
Cash flow statement
| Operating cash flow (ttm) | 4.02B |
| Levered free cash flow (ttm) | 2.52B |
© 2022 Yahoo. All rights reserved.
